Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

1.39USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$1.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,309
52-wk High
$4.49
52-wk Low
$1.03

Chart for

About

Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the... (more)

Overall

Beta: 1.48
Market Cap(Mil.): $92.37
Shares Outstanding(Mil.): 35.94
Dividend: --
Yield (%): --

Financials

  OPHT.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -5.39 -- --
ROI: -73.71 8.99 14.96
ROE: -- 10.13 16.53

Earnings vs. Estimates